Product Details
Additional Information
| Product Name | Tagrisso 80 mg Tablet |
| Application | Anticancer Agent (Tyrosine Kinase Inhibitor) |
| Drug Class | Tyrosine kinase inhibitor (TKI) |
| Generic Drug Name | Osimertinib |
| Mechanism of Action | Inhibits mutant EGFR (T790M) and other EGFR mutations, blocking cancer cell proliferation |
| Strength | 80 mg |
| Type | Oral (Oral tablet) |
| Side Effects | Diarrhea, skin rash, fatigue, lung disease, cardiac effects |
| Special Precautions | Monitor for lung issues (ILD), cardiac events, and liver function |
| Pregnancy Category | Category D (risk to fetus) |
| Container Type | Bottle |
| Quantity | 30 Tablets |
| Uses | Treatment of EGFR-mutated non-small cell lung cancer (NSCLC) with T790M mutation |
Description
Tagrisso (osimertinib) is an oral medication used to treat non-small cell lung cancer (NSCLC) with specific mutations in the epidermal growth factor receptor (EGFR) gene, such as the T790M mutation. It is particularly indicated for patients who have experienced disease progression on previous EGFR-targeted therapies.
The active ingredient in Tagrisso, osimertinib, is a third-generation tyrosine kinase inhibitor (TKI). By binding to and inhibiting the mutated EGFR, it prevents the proliferation of cancer cells, ultimately slowing disease progression and improving patient outcomes. Its selective inhibition helps minimize effects on normal, non-cancerous cells, which improves the tolerability of the drug.
Common side effects of Tagrisso include diarrhea, skin rashes, and fatigue. Patients may also experience more severe adverse reactions like interstitial lung disease or cardiac issues, which necessitate prompt medical attention.
Frequently Asked Questions (FAQs)
The cost of Tagrisso 80 Mg Tablet is $available for registerd members only
Tagrisso 80 Mg Tablet is manufactured by ASTRAZENECA.
You can purchase Tagrisso 80 Mg Tablet on our website at https://supplies.pipelinemedical.com/product/detail/tagrisso-80-mg-tablet-425843